Slideshow Articles

Looking for a Functional Cure

Friday, October 24, 2014

ViaCyte, a San Diego-based company, has been working on a combination stem cell-derived product and delivery system that is aiming to treat people with insulin-dependent diabetes.

Human-embryonic-stem-cells

Engineering Stem Cells

ViaCyte was the first company to engineer human embryonic stem cells into definitive endoderm, the gatekeeper cells that differentiate into pancreas, liver and other cells, tissues, and organs.

2 of 5